Cargando…

C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia

Transcription factor MYB has recently emerged as a promising drug target for the treatment of acute myeloid leukemia (AML). Here, we have characterized a group of natural sesquiterpene lactones (STLs), previously shown to suppress MYB activity, for their potential to decrease AML cell proliferation....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yusenko, Maria V., Trentmann, Amke, Casolari, Debora A., Abdel Ghani, Luca, Lenz, Mairin, Horn, Melanie, Dörner, Wolfgang, Klempnauer, Stefan, Mootz, Henning D., Arteaga, Maria Francisca, Mikesch, Jan-Henrik, D’Andrea, Richard J., Gonda, Thomas J., Müller-Tidow, Carsten, Schmidt, Thomas J., Klempnauer, Karl-Heinz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298201/ https://www.ncbi.nlm.nih.gov/pubmed/33958723 http://dx.doi.org/10.1038/s41388-021-01800-x

Ejemplares similares

Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module
por: Schmidt, Thomas J., et al.
Publicado: (2022)

Src-Family Protein Kinase Inhibitors Suppress MYB Activity in a p300-Dependent Manner
por: Biyanee, Abhiruchi, et al.
Publicado: (2022)

A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity
por: Yusenko, Maria, et al.
Publicado: (2018)

C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells
por: Klempnauer, Karl-Heinz
Publicado: (2023)

The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression
por: Coulibaly, Anna, et al.
Publicado: (2018)

Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins
por: Cibis, Hannah, et al.
Publicado: (2020)

Multimodal 4-arylchromene derivatives with microtubule-destabilizing, anti-angiogenic, and MYB-inhibitory activities
por: Köhler, Leonhard H. F., et al.
Publicado: (2023)

Oncogenic point mutations in the Myb DNA-binding domain alter the DNA-binding properties of Myb at a physiological target gene
por: Ivanova, Olga, et al.
Publicado: (2007)

Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity
por: Yusenko, Maria V., et al.
Publicado: (2021)

Interaction of the Transactivation Domain of B-Myb with the TAZ2 Domain of the Coactivator p300: Molecular Features and Properties of the Complex
por: Oka, Ojore, et al.
Publicado: (2012)

The promoter regions of the Myb-regulated Adora2B and Mcm4 genes co-localize with origins of DNA replication
por: Gundelach, Holger, et al.
Publicado: (2007)

Activation of the oncogenic transcription factor B-Myb via multisite phosphorylation and prolyl cis/trans isomerization
por: Werwein, Eugen, et al.
Publicado: (2019)

B-Myb switches from Cyclin/Cdk-dependent to Jnk- and p38 kinase-dependent phosphorylation and associates with SC35 bodies after UV stress
por: Werwein, E, et al.
Publicado: (2013)

PRMT4 Is a Novel Coactivator of c-Myb-Dependent Transcription in Haematopoietic Cell Lines
por: Streubel, Gundula, et al.
Publicado: (2013)

Epidemiological studies of the leukemogenic effects of radiation.
por: Lilienfeld, A. M.
Publicado: (1966)

The Leukemogenic Action of Estrogens in Hybrid Mice
por: Gardner, W. U., et al.
Publicado: (1944)

STAT activation status differentiates leukemogenic from non-leukemogenic stem cells in AML and is suppressed by arsenic in t(6;9)-positive AML
por: Oancea, Claudia, et al.
Publicado: (2014)

Using Bioinformatic Approaches to Identify Pathways Targeted by Human Leukemogens
por: Thomas, Reuben, et al.
Publicado: (2012)

The mechanism of MYB transcriptional regulation by MLL-AF9 oncoprotein
por: Cao, Lu, et al.
Publicado: (2019)

Dominant-Negative Mechanism of Leukemogenic PAX5 Fusions
por: Kawamata, Norihiko, et al.
Publicado: (2011)

MYB suppresses differentiation and apoptosis of human breast cancer cells
por: Drabsch, Yvette, et al.
Publicado: (2010)

Interplay with the Mre11-Rad50-Nbs1 complex and phosphorylation by GSK3β implicate human B-Myb in DNA-damage signaling
por: Henrich, Sarah Marie, et al.
Publicado: (2017)

Leukemogenic Ptpn11 Allele Causes Defective Erythropoiesis in Mice
por: Usenko, Tatiana, et al.
Publicado: (2014)

The Myb-p300-CREB axis modulates intestine homeostasis, radiosensitivity and tumorigenesis
por: Sampurno, S, et al.
Publicado: (2013)

c-Myb and C/EBPβ regulate OPN and other senescence-associated secretory phenotype factors
por: Flanagan, Kevin C., et al.
Publicado: (2017)

Nucleophosmin leukemogenic mutant activates Wnt signaling during zebrafish development
por: Barbieri, Elisa, et al.
Publicado: (2016)

Redox metabolism maintains the leukemogenic capacity and drug resistance of AML cells
por: Huang, Dan, et al.
Publicado: (2023)

Pubic and inguinal venous collaterals mimic inguinal hernia
por: Oldhafer, F., et al.
Publicado: (2017)

Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish
por: Lu, J-W, et al.
Publicado: (2017)

Ascites Drainage Leading to Intestinal Adhesions at the Mesentery of the Small Intestine with Fatal Outcome
por: Kettler, B., et al.
Publicado: (2014)

Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity
por: Azran, Inbal, et al.
Publicado: (2004)

Indirect induction of radiation lymphomas in mice. Evidence for a novel, transmissible leukemogen
Publicado: (1987)

Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways
por: Gow, Chien-Hung, et al.
Publicado: (2014)

Rapid Generation of Leukemogenic Chromosomal Translocations in Vivo Using CRISPR/Cas9
por: Huang, Yun, et al.
Publicado: (2020)

Estrogen receptor-α recruits P-TEFb to overcome transcriptional pausing in intron 1 of the MYB gene
por: Mitra, Partha, et al.
Publicado: (2012)

Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts
por: Massimino, Michele, et al.
Publicado: (2021)

Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells
por: Fortin, Jerome, et al.
Publicado: (2023)

Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice
Publicado: (1980)

Characterization of the leukemogenic potential of distal cytoplasmic CSF3R truncation and missense mutations
por: Zhang, Haijiao, et al.
Publicado: (2017)

Translation, Pdcd4 and eIF4A
por: Biyanee, Abhiruchi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gasedd8ugqhegu8rms7tjffudt